Are you a new member? Sign up now
Login area
| Sign up
close
STIVANT - 100mg/4ml - 1x4ml
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FG01 | BioTech | Bevacizumab - 100mg/4ml | 10324 | 175219/1 | STIVANT | 100mg/4ml | 1x4ml | Injectable concentrate for solution | Infusion | Lebiran SARL | Aryogen Pharmed | Iran | 14,719,570 L.L | 19.35 | D | Aryogen Pharmed | Iran | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FG01 | BioTech | Bevacizumab - 100mg/4ml | 5554 | 221325/08 | AVASTIN | 100mg/4ml | 1 x 4ml | Injectable concentrated solution | Infusion | Omnipharma | F. Hoffmann La Roche Manufacturing Site Kaiseraugst | Switzerland | 24,533,456 L.L | 19.35 | D | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
| L01FG01 | BioTech | Bevacizumab - 100mg | 6109 | 167512/10 | AVASTIN | 100mg | 1 x 4ml | Injectable concentrated solution | Infusion | Omnipharma | Roche Diagnostics GmbH | Germany | 24,533,456 L.L | 19.35 | D | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |
| L01FG01 | BioTech | Bevacizumab - 100mg/4ml | 11597 | 107023/1 | BEVACIREL | 100mg/4ml | 1x4ml | Injectable solution | Infusion | Levant Pulse SARL | Reliance Life Sciences pvt Ltd | India | 14,719,570 L.L | 19.35 | D | India | 2/5/2024 | 0 | |
| L01FG01 | BioTech | Bevacizumab - 100mg/4ml | 11666 | 130823/1 | BIVASTINA 100 | 100mg/4ml | 1x4ml | Injectable concentrate for solution | Infusion | Benta Trading Co s.a.l. | Manufactured by JSC Biocad, Russia for Benta SAL | Lebanon | 18,490,076 L.L | 19.35 | D | 2/5/2024 | 0 | ||
| L01FG01 | BioTech | Bevacizumab - 100mg/4ml | 10795 | 96721/1 | BIVASTINA 100 | 100mg/4ml | 2x4ml | Injectable concentrate for solution | Infusion | Benta Trading Co s.a.l. | Manufactured by JSC Biocad, Russia for Benta SAL | Lebanon | 47,495,416 L.L | 10.71 | E1 | 2/5/2024 | 0 | ||
| L01FG01 | BioTech | Bevacizumab - 100mg/4ml | 10519 | 100520/1 | MVASI | 100mg/4ml | 1x4ml | Injectable concentrate for solution | Infusion | Mersaco | Amgen Manufacturing Ltd | USA | 17,173,671 L.L | 19.35 | D | Amgen Technology (Ireland) Unlimited Company | Ireland | 2/5/2024 | 0 |
| L01FG01 | BioTech | Bevacizumab - 100mg/4ml | 10287 | 100120/1 | ZIRABEV | 100mg/4ml | 1 | Injectable solution | Infusion | Droguerie Fattal S.A.L. | Pharmacia & Upjohn Company LLC | USA | 17,173,671 L.L | 19.35 | D | Pfizer Inc | USA | 2/5/2024 | 0 |
| L01FG01 | BioTech | Bevacizumab - 100mg/4ml | 11597/388 | 107023/1 | BEVACIREL | 100mg/4ml | 1x4ml | Injectable solution | Infusion | Levant Pulse SARL | Reliance Life Sciences pvt Ltd | India | L.L | 19.35 | D | India | 2/5/2024 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024